Although an increase in VEGF levels pre-ATRA treatment in Cycle 2 could indicate that ATRA treatment in Cycle 1 increased VEGF expression, causing angiogenesis, there is also the possibility that VEGF was elevated due to tumor-driven angiogenesis, resulting from hypoxia. Here, VEGFA is linked to neoplasm.